18.32% -0.2088

Trevena Inc (TRVN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Trevena Inc Borsa (TRVN) Ultime notizie

Trevena Inc (TRVN)

Trevena Inc Borsa (TRVN) Ultime notizie

Aegle Therapeutics Names Industry Veteran Scott Braunstein, M.D. as Chairman of the Board - The Manila Times

Is Trevena, Inc. overvalued or undervalued? - MarketsMojo

RAPT Therapeutics Names Two Industry Veterans to its Board of Directors - GlobeNewswire

Trevena (NASDAQ:TRVN) Stock Price Crosses Below 200-Day Moving Average – Here’s What Happened - Defense World

TREVENA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Trevena, Inc. To Contact The Firm - ACCESS Newswire

Acute Pain Drug Pipeline Analysis: Market Overview, Trends, and Future Growth (2034) - openPR.com

Trevena to Present at the H.C. Wainwright Global Investment Conference - The Globe and Mail

Opioid Drugs Market in 2025-2032 Detailed Study Analysis with - openPR.com

Financial Comparison: Adicet Bio (NASDAQ:ACET) & Trevena (NASDAQ:TRVN) - Defense World

Behind the Booth at InfoComm 2025: An Interview With tvONE’s Mark Trevena - rAVe [PUBS]

Trevena (TRVN) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws; Investors Who Suffered Losses Exceeding $50,000 Encouraged to Contact the Firm - ACCESS Newswire

COVID-19 Therapeutics Market Current Scenario with Future Aspect Analysis - openPR.com

Opioid Drugs Market: Investment Analysis & Growth Opportunity - openPR.com

Highest-Paid CEOs2024 - AFL-CIO

Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com - Defense World

Biopharma Dealmaking Quarterly Statistics, Q2 2013 - insights.citeline.com

Block & Leviton Files Securities Class Action Against Trevena, Inc. (TRVN); Investors Who Suffered Losses Exceeding $50,000 Are Encouraged to Contact The Firm - ACCESS Newswire

Trevena (NASDAQ:TRVN) Earns Sell Rating from Analysts at StockNews.com - Defense World

Aviation Co. Says Workers' Class Action Too Broad - Law360

Block & Leviton Reminds Shareholders of Securities Class Action Against Trevena, Inc. (TRVN); Investors Who Suffered Losses Exceeding $50,000 Are Encouraged to Contact The Firm - ACCESS Newswire

Press Release Distribution & PR Platform - ACCESS Newswire

StockNews.com Initiates Coverage on Trevena (NASDAQ:TRVN) - Defense World

Trevena (NASDAQ:TRVN) Stock Crosses Below 200 Day Moving Average – Time to Sell? - Defense World

Opioid Drugs Market Detailed In New Research Report 2025-2032 | - openPR.com

Trevena Delays Yearly Report Filing - TipRanks

Trevena (TRVN) Expected to Announce Quarterly Earnings on Monday - Defense World

Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc.; Mountain Crest Acquisition Corp. V - The Manila Times

Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of CAN-2409 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatm - The Manila Times

Global Post Operative Pain Management Market Advancements Highlighted by Forecast: Key Growth Drivers, Tren... - WhaTech

Ten option delistings on March 24th - TipRanks

Trevena (NASDAQ:TRVN) Stock Price Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World

StockNews.com Begins Coverage on Trevena (NASDAQ:TRVN) - The AM Reporter

Opioid Drugs Market to Witness Remarkable Growth with Johnson & Johnson, Endo International plc - openPR

Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com - Defense World

Trevena, Inc. to Host Earnings Call - ACCESS Newswire

Trevena (NASDAQ:TRVN) Now Covered by StockNews.com - Defense World

Opioid Drugs Market Growth, Demand Trends, Size & Competitive - openPR

Trevena (NASDAQ:TRVN) Research Coverage Started at StockNews.com - Defense World

Promising Automotive Stocks To Keep An Eye On – February 04th - ETF Daily News

Trevena Announces Board and Executive ChangesOn January 31, 2025, Trevena, Inc. (NASDAQ:TRVN) filed a Form 8-K with the Securities and Exchange Commission, detailing significant departures and appointments within the company.In line with ongoin - Defense World

Trevena Implements Cost-Cutting Measures Amid Leadership Changes - TipRanks

Trevena (NASDAQ:TRVN) Shares Cross Below 200 Day Moving Average – Time to Sell? - Defense World

Trevena discontinues OLINVYK injection sales By Investing.com - Investing.com Canada

Simile a TRVN